What happens if President Trump cuts billions of dollars from research on how to make our health care system work better?
Health Policy Research
Posted inInsurance
Unpacking the Health Impacts of Republicans’ ‘Big Beautiful Bill’
On June 18, Tradeoffs moderated an online event with economists and doctors examining why this legislation could cost so many people their health coverage — or even their lives.
Posted inInsurance
New Studies Show How Cutting Medicaid Could Be Deadly
Two new studies inject powerful evidence into the heated Medicaid debate in Washington, showing the public insurance program is saving lives.
Cogent & Concise: Finding the Story in Your Study
Cogent & Concise: Finding the Story in Your Study is hosted by the Association for Public Policy Analysis & Management. In today’s environment, researchers must not only possess subject matter […]
Posted inPublic Health
Making Sense of Sweeping Cuts at HHS
Veteran health care reporter Julie Rovner breaks down the massive cuts and reorganization at HHS and answers listeners’ questions about what to expect next.
Posted inPublic Health
The Cost of Cutting NIH Research: Voices from the Frontlines
A candid conversation between a professor and a Ph.D. candidate about potential NIH funding cuts and their impact on the future of medical research.
Posted inHealth Technology
Lots of Hospitals Are Using AI. Few Are Testing For Bias
New research sheds light on how many hospitals are using artificial intelligence, what they’re using AI for, and what it means for patients and policymakers.
Posted inPublic Health
The Stories That Made an Impact in 2023
In this special episode we reflect on a few of our favorite stories of 2023 and hear how they’re making a difference for patients and policymakers.
Posted inPublic Health
When Research and the Realities of Practicing Medicine Collide
Tradeoffs research reporter Soleil Shah shares what he’s learning as a new medical resident about the value and limitations of health policy research.
Posted inPublic Health
Drugmakers and Patient Assistance Programs: Tricks or Treats?
Stacie Dusetzina shares new research that examines the link between drug companies’ charity donations and their business incentives.